| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > PR > Managers: A Key to Your Survival |
|
Advice You - Managers: A Key to Your Survival
Most business, non-profit and association managers live to tell about it only IF they achieve their operating objectives. Very little wriggle room there. But among such managers are those who fail to do anything about the behaviors of those outside audiences that most affect their business, non-profit or According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product association. On top of that omission, they risk their careers by choosing to pursue their operating objectives without using the fundamental premise of public relations. Thus, they fail to produce external stakeholder behavior change leading directly to achieving those very same managerial objectives. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in Then, despite the wonder of it all, they end up failing to persuade those important outside folks to their way of thinking and, finally, fail to move them to take actions that help their department, division or subsidiary succeed. Wow! Why would any clear thinking manager operate that way? I don’t know why lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. . What I DO know is that they can start turning things around in a New York minute! Best advice? Start with that fundamental premise of public relations mentioned above, because it’s the action blueprint you need to reach your objectives. People act on their own perception of the facts before them, whic here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe h leads to predictable behaviors about which something can be done. When we create, change or reinforce that opinion by reaching, persuading and moving-to-desired- action the very people whose behaviors affect the organization the most, the public relations mission is accomplished. There’s no end to the d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro number and variety of results this process can achieve -- politicians and legislators starting to view you as a key member of the business, non-profit or association communities; prospects starting to do business with you; community leaders beginning to seek you out; fresh proposals for strategic allian ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ces and joint ventures; growing numbers of membership applications; customers starting to make repeat purchases; a welcome jump in sales floor visits; and even capital givers or specifying sources beginning to look your way. Enlist the PR folks assigned to your unit and spend some time with them nailing easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi down those outside audiences whose behaviors help or hurt you in achieving your objectives. Then list them according to how severely they impact your operation. For starters, select the audience in first place on your list. I would guess that you have very little current input as to how most members of nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically that key outside audience perceive your organization. Of course, these data would be available to you if you had been regularly sampling those perceptions. If the budget isn’t there to defray the cost of professional survey work, your PR team will have to monitor those perceptions by interacting with mem and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ bers of that outside audience. Ask questions like “Have you ever had contact with anyone from our organization?” And, “Was it a satisfactory experience?” And, “Are you familiar with our services or products?” Your team must watch closely for negative statements, especially evasive or hesitant replies. S ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi tay alert for false assumptions, untruths, misconceptions, inaccuracies and potentially hurtful rumors. When you find such damaging perceptions, they will need to be corrected, because experience shows they usually lead to negative behaviors. The trick is to do something about such negativity before it ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a morphs into injurious behavior. Which means you now pick the specific perception to be altered. Not surprisingly, that becomes your public relations goal. Now, the reality is that a PR goal without a strategy to show you how to get there is like a meatball without a cheesy center. That’s why you must sel dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ect one of three strategies especially designed to create perception or opinion where there may be none, or change existing perception, or reinforce it. The challenge here is to insure that the goal and its strategy match each other. You wouldn’t want to select “change existing perception” when current cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin perception is just right, suggesting a “reinforce” strategy. Good writing required here. Somebody has to prepare a really compelling message carefully designed to alter your key target audience’s perception, as required by your public relations goal. Be careful here. Combine your corrective message with tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen another newsworthy announcement of a new product, service or employee, which may lend credibility by not giving too much emphasis to the correction. As you might suspect, the message also must have several values. For example, clarity. Also, your facts must be truthful and your position on the inaccurac t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel y must be persuasive, logically explained and believable if it is to hold the attention of members of that target audience, and actually move perception your way. Now things get more relaxing. Namely, choosing the actual tactics you will use to carry your persuasive new thoughts to the attention of that ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust external audience. And there is no shortage of such tactics. For instance, radio and newspaper interviews, personal contacts, newsletters, letters-to-the-editor, brochures, press releases and speeches. Or, you might settle on group briefings, special events or facility tours, always making sure those t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products actics you select have a record of reaching the same audiences as those that make up your target stakeholders. Sorry, but you will be queried about progress and will have to once again monitor perceptions among your target audience members. And with a line of questioning similar to that used during your . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de earlier monitoring session. The difference now is that you must stay on the lookout for indications that audience perceptions are beginning to move in your direction. But this is our lucky day. We can always expedite matters and speed up the process by employing additional communications tactics, AND by elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip increasing their frequencies. My experience has been that business, non-profit and association managers survive very nicely, thank you, when they sharpen their focus on the very groups of outside people who play a major role in just how successful a manager they will be – their key external stakeholders. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Brilliant Strategist or Lawyer or Not Bring Forth Your Inherent Negotiating Skills With Mind Mapping Advantages of Offshore Outsourcing in Information Technology
|